3229-2841 Screening compound: 2-[(E)-{2-[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-[(1Z)-2-(2,4-dichlorophenyl)diazen-1-yl]phenol

3229-2841 Screening compound: 2-[(E)-{2-[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-[(1Z)-2-(2,4-dichlorophenyl)diazen-1-yl]phenol
3229-2841 Screening compound: 2-[(E)-{2-[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-[(1Z)-2-(2,4-dichlorophenyl)diazen-1-yl]phenol alternative view

Chemical Structure Depiction of ChemDiv screening compound 3229-2841
2-[(E)-{2-[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-[(1Z)-2-(2,4-dichlorophenyl)diazen-1-yl]phenol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3229-2841

Molecular Formula

C28H21Cl2N9O (C28 H21 Cl2 N9 O)

Compound Name

2-[(E)-{2-[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-[(1Z)-2-(2,4-dichlorophenyl)diazen-1-yl]phenol

IUPAC name

2-[(E)-{2-[46-bis(phenylamino)-135-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-[(1Z)-2-(24-dichlorophenyl)diazen-1-yl]phenol

SMILES

Oc(cc1)c(/C=N/Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)cc1/N=N\c(ccc(Cl)c1)c1Cl

InChI

InChI=1S/C28H21Cl2N9O/c29-19-11-13-24(23(30)16-19)38-37-22-12-14-25(40)18(15-22)17-31-39-28-35-26(32-20-7-3-1-4-8-20)34-27(36-28)33-21-9-5-2-6-10-21/h1-17,40H,(H3,32,33,34,35,36,39)

InChI Key

LGOUUVNCGDKPSP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01207225

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

570.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

9.393

Distribution Coefficient, logD

9.389

Water Solubility, LogSw

-6.45

Polar Surface Area

110.007

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

4.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

3229-2841 in Drug Discovery

Included in Screening Libraries

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 3229-2841 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3229-2841?
Check Price and Availability of 3229-2841, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3229-2841 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3229-2841
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3229-2841
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3229-2841 available by request